Zinc-free and low-zinc insulin preparations having improved stability
First Claim
Patent Images
1. A formulation comprising:
- Lys(B3),Glu(B29) human insulin;
a compound chosen from polysorbate 20, polysorbate 80, and poloxamer 171; and
water,wherein the formulation is free from zinc or contains less than 0.2% by weight of zinc based on the insulin content of the formulation.
0 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to a formulation comprising a polypeptide selected from at least one of insulin, an insulin metabolite, an insulin analog, and an insulin derivative; at least one surfactant; optionally at least one preservative; and optionally at least one of an isotonicizing agent, a buffer or an excipient, wherein the formulation is free from or low in zinc. The invention also relates to the production of such insulin preparations and their use as pharmaceutical formulations.
83 Citations
19 Claims
-
1. A formulation comprising:
-
Lys(B3),Glu(B29) human insulin; a compound chosen from polysorbate 20, polysorbate 80, and poloxamer 171; and water, wherein the formulation is free from zinc or contains less than 0.2% by weight of zinc based on the insulin content of the formulation. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
-
9. A method of treating diabetes mellitus comprising administering a formulation comprising:
-
Lys(B3),Glu(B29) human insulin; a compound chosen from polysorbate 20, polysorbate 80, and poloxamer 171; and water, wherein the formulation is free from zinc or contains less than 0.2% by weight of zinc based on the insulin content of the formulation. - View Dependent Claims (10, 11, 12, 13, 14, 15, 16)
-
-
17. A method of making a formulation comprising Lys(B3),Glu(B29) human insulin;
- a compound chosen from polysorbate 20, polysorbate 80, and poloxamer 171; and
water, wherein the formulation is free from zinc or contains less than 0.2% by weight of zinc based on the insulin content of the formulation;
said method comprising;
dissolving the Lys(B3),Glu(B29) human insulin in the water, adding the compound chosen from polysorbate 20, polysorbate 80, and poloxamer 171, and optionally adding a final volume of water. - View Dependent Claims (18, 19)
- a compound chosen from polysorbate 20, polysorbate 80, and poloxamer 171; and
Specification